TY  - JOUR
AU  - Tichanek, Filip
AU  - Försti, Asta
AU  - Hemminki, Akseli
AU  - Hemminki, Otto
AU  - Hemminki, Kari
TI  - Survival in melanoma in the nordic countries into the era of targeted and immunological therapies.
JO  - European journal of cancer
VL  - 186
SN  - 0014-2964
CY  - Amsterdam [u.a.]
PB  - Elsevier
M1  - DKFZ-2023-00773
SP  - 133 - 141
PY  - 2023
N1  - #LA:C020#
AB  - Survival in melanoma has been increasing and the most recent interest is to observe the population-level impact of novel targeted therapies and immunotherapy. We analysed survival in melanoma from Denmark (DK), Finland (FI), Norway (NO) and Sweden (SE) over a 50-years period (1971-2020).Relative 1-5/1- and 5-year survival data were obtained from the NORDCAN database for the years 1971-2020. We estimated annual changes in survival rates and determined significant breaking points for trends.Survival in melanoma has reached the point where 1-year survival is approaching 100
KW  - Conditional survival (Other)
KW  - Immunotherapy (Other)
KW  - Relative survival (Other)
KW  - Sun protection (Other)
KW  - Targeted therapy (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:37068406
DO  - DOI:10.1016/j.ejca.2023.03.019
UR  - https://inrepo02.dkfz.de/record/275458
ER  -